Infusion procedures

FDA Approves Onapgo: Breakthrough Infusion Device for Advanced Parkinson’s Disease

3 months ago talkbio0Tagged apomorphine hydrochloride, Approved, Infusion procedures, motor fluctuations, Onapgo, Parkinson 's disease, subcutaneous, Supernus, United States Food and Drug Administration

Onapgo, apomorphine hydrochloride, Parkinson’s disease, subcutaneous infusion, motor fluctuations, FDA approval, Supernus Pharmaceuticals

Vertex’s CASGEVY Marks Historic Milestone with First Commercial Patient Infusions, Paving the Way for 2025 Launches

6 months ago talkbio0Tagged Anemia, Sickle Cell, Approved, Casgevy, commercial, CRISPR/Cas9, gene therapy, Infusion procedures, launches, United States Food and Drug Administration

CASGEVY, Vertex Pharmaceuticals, gene therapy, sickle cell disease, beta thalassemia, CRISPR/Cas9, FDA approval, commercial patient infusions, 2025 launches.

FDA Approves Vyalev: A Breakthrough Continuous Infusion Therapy for Advanced Parkinson’s Disease

6 months ago talkbio0Tagged AbbVie, Approved, carbidopa, Continuous, Infusion procedures, levodopa, motor fluctuations, Parkinson Disease, United States Food and Drug Administration, Vyalev

Vyalev, Parkinson’s disease, continuous infusion therapy, FDA approval, AbbVie, motor fluctuations, levodopa, carbidopa

Bicycle Therapeutics Gears Up for Future Milestones with $555 Million Capital Infusion

11 months ago talkbio0Tagged Bicycle, Biotechnology, Capital, Catalyst, Clinical Trials, Drug Development, Infusion procedures, investors, milestones

Bicycle Therapeutics, funding, catalysts, biotechnology, drug development, clinical trials, investors, capital infusion, milestones.